Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Convertible Warrants

Ind-Swift Laboratories Convertible Warrants

Essix Biosciences Limited acquired 14,00,000 equity shares of Ind-Swift Laboratories Limited following the conversion of fully convertible warrants. The company disclosed this under SEBI regulations.

Source

BSE filing, NSE: INDSWFTLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Ind-Swift Laboratories Ltd: key numbers

Share price
₹378.95
Market cap
₹3,295 Cr
Revenue (annual)
₹649.1 Cr
Net profit (annual)
₹43.12 Cr
P/E (TTM)
57.5×Sector 46.1×
Promoter holding
42.93%+0.00% QoQ
FII holding
10.78%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Ind-Swift Laboratories Ltd

All →

Other convertible warrants announcements

All →